APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Transforming Growth Factor-β

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Human Transforming Growth Factor-β Industry Growth and Trends Forecast to 2032

Report ID 174031660126 December 2025128 pages

Choose your research edition.

Industry ResearchRecombinant Human Transforming Growth Factor-β Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Transforming Growth Factor-β Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Recombinant Human Transforming Growth Factor-β Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Transforming Growth Factor-β Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Transforming Growth Factor-β Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Recombinant Human Transforming Growth Factor-β market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Transforming Growth Factor-β include Abcam, ACROBiosystems, Atlantis Bioscience, Bio-Techne, Cell Guidance Systems, Cell Signaling Technology, Croyez Bioscience, FUJIFILM Irvine Scientific and MedChemExpress, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Human Transforming Growth Factor-β market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Human Transforming Growth Factor-β market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Human Transforming Growth Factor-β market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Human Transforming Growth Factor-β.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Human Transforming Growth Factor-β market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Human Transforming Growth Factor-β Market by Company

Abcam

ACROBiosystems

Atlantis Bioscience

Bio-Techne

Cell Guidance Systems

Cell Signaling Technology

Croyez Bioscience

FUJIFILM Irvine Scientific

MedChemExpress

Miltenyi Biotec

Proteintech

Qkine

Sigma-Aldrich

Beijing T&L Biotechnology

Beijing Sino Biological

Dalian Meilun Biotechnology

Cellverse

Nanjing Okay Biotechnology

Thermo Fisher

Shanghai DiLab Biotechnology

Shanghai Zhong Qiao Xin Zhou Biotechnology

Suzhou Novoprotein Scientific

Abbkine Scientific

EIAAB SCIENCE

Yeasen Biotechnology (Shanghai)

Recombinant Human Transforming Growth Factor-β Segment by Type

TGF-β3

TGF-β2

TGF-β1

Recombinant Human Transforming Growth Factor-β Segment by Application

Hospital

Research Institute

Others

Recombinant Human Transforming Growth Factor-β Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Transforming Growth Factor-β market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Transforming Growth Factor-β and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Transforming Growth Factor-β.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Transforming Growth Factor-β manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Human Transforming Growth Factor-β in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of TGF-β3 Table 2. Major Company of TGF-β2 Table 3. Major Company of TGF-β1 Table 4. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 6. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Type (2021-2026) Table 7. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (US$ Million) Table 8. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Type (2021-2026) Table 9. Global Recombinant Human Transforming Growth Factor-β Price by Type (2021-2026) & (US$/Unit) Table 10. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 11. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Type (2027-2032) Table 12. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (US$ Million) Table 13. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Type (2027-2032) Table 14. Global Recombinant Human Transforming Growth Factor-β Price by Type (2027-2032) & (US$/Unit) Table 15. North America Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 16. North America Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 18. Europe Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 22. Latin America Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (US$ Million) Table 25. Recombinant Human Transforming Growth Factor-β Industry Trends Table 26. Recombinant Human Transforming Growth Factor-β Industry Drivers Table 27. Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges Table 28. Recombinant Human Transforming Growth Factor-β Industry Restraints Table 29. Global Recombinant Human Transforming Growth Factor-β Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Company (2021-2026) Table 31. Global Recombinant Human Transforming Growth Factor-β Sales by Company (2021-2026) & (K Units) Table 32. Global Recombinant Human Transforming Growth Factor-β Sales Share by Company (2021-2026) Table 33. Global Recombinant Human Transforming Growth Factor-β Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Recombinant Human Transforming Growth Factor-β Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Recombinant Human Transforming Growth Factor-β Major Company Production Sites and Headquarters Table 36. Global Recombinant Human Transforming Growth Factor-β Company, Product Type & Application Table 37. Global Recombinant Human Transforming Growth Factor-β Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Recombinant Human Transforming Growth Factor-β by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Recombinant Human Transforming Growth Factor-β Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026) & (K Units) Table 42. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Region (2021-2026) Table 43. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026) & (US$ Million) Table 44. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Region (2021-2026) Table 45. Global Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2027-2032) & (K Units) Table 47. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Region (2027-2032) Table 48. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2027-2032) & (US$ Million) Table 49. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Region (2027-2032) Table 50. Global Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 53. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Application (2021-2026) Table 54. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (US$ Million) Table 55. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Application (2021-2026) Table 56. Global Recombinant Human Transforming Growth Factor-β Price by Application (2021-2026) & (US$/Unit) Table 57. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 58. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Application (2027-2032) Table 59. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (US$ Million) Table 60. Global Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Application (2027-2032) Table 61. Global Recombinant Human Transforming Growth Factor-β Price by Application (2027-2032) & (US$/Unit) Table 62. North America Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 63. North America Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 65. Europe Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 69. Latin America Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (US$ Million) Table 72. Abcam Company Information Table 73. Abcam Business Overview Table 74. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio Table 76. Abcam Recent Development Table 77. ACROBiosystems Company Information Table 78. ACROBiosystems Business Overview Table 79. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 81. ACROBiosystems Recent Development Table 82. Atlantis Bioscience Company Information Table 83. Atlantis Bioscience Business Overview Table 84. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 86. Atlantis Bioscience Recent Development Table 87. Bio-Techne Company Information Table 88. Bio-Techne Business Overview Table 89. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio Table 91. Bio-Techne Recent Development Table 92. Cell Guidance Systems Company Information Table 93. Cell Guidance Systems Business Overview Table 94. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 96. Cell Guidance Systems Recent Development Table 97. Cell Signaling Technology Company Information Table 98. Cell Signaling Technology Business Overview Table 99. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 101. Cell Signaling Technology Recent Development Table 102. Croyez Bioscience Company Information Table 103. Croyez Bioscience Business Overview Table 104. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 106. Croyez Bioscience Recent Development Table 107. FUJIFILM Irvine Scientific Company Information Table 108. FUJIFILM Irvine Scientific Business Overview Table 109. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 111. FUJIFILM Irvine Scientific Recent Development Table 112. MedChemExpress Company Information Table 113. MedChemExpress Business Overview Table 114. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio Table 116. MedChemExpress Recent Development Table 117. Miltenyi Biotec Company Information Table 118. Miltenyi Biotec Business Overview Table 119. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio Table 121. Miltenyi Biotec Recent Development Table 122. Proteintech Company Information Table 123. Proteintech Business Overview Table 124. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio Table 126. Proteintech Recent Development Table 127. Qkine Company Information Table 128. Qkine Business Overview Table 129. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio Table 131. Qkine Recent Development Table 132. Sigma-Aldrich Company Information Table 133. Sigma-Aldrich Business Overview Table 134. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio Table 136. Sigma-Aldrich Recent Development Table 137. Beijing T&L Biotechnology Company Information Table 138. Beijing T&L Biotechnology Business Overview Table 139. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 141. Beijing T&L Biotechnology Recent Development Table 142. Beijing Sino Biological Company Information Table 143. Beijing Sino Biological Business Overview Table 144. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio Table 146. Beijing Sino Biological Recent Development Table 147. Dalian Meilun Biotechnology Company Information Table 148. Dalian Meilun Biotechnology Business Overview Table 149. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 151. Dalian Meilun Biotechnology Recent Development Table 152. Cellverse Company Information Table 153. Cellverse Business Overview Table 154. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio Table 156. Cellverse Recent Development Table 157. Nanjing Okay Biotechnology Company Information Table 158. Nanjing Okay Biotechnology Business Overview Table 159. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 161. Nanjing Okay Biotechnology Recent Development Table 162. Thermo Fisher Company Information Table 163. Thermo Fisher Business Overview Table 164. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio Table 166. Thermo Fisher Recent Development Table 167. Shanghai DiLab Biotechnology Company Information Table 168. Shanghai DiLab Biotechnology Business Overview Table 169. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 171. Shanghai DiLab Biotechnology Recent Development Table 172. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 173. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 174. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 176. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development Table 177. Suzhou Novoprotein Scientific Company Information Table 178. Suzhou Novoprotein Scientific Business Overview Table 179. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 181. Suzhou Novoprotein Scientific Recent Development Table 182. Abbkine Scientific Company Information Table 183. Abbkine Scientific Business Overview Table 184. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 186. Abbkine Scientific Recent Development Table 187. EIAAB SCIENCE Company Information Table 188. EIAAB SCIENCE Business Overview Table 189. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio Table 191. EIAAB SCIENCE Recent Development Table 192. Yeasen Biotechnology (Shanghai) Company Information Table 193. Yeasen Biotechnology (Shanghai) Business Overview Table 194. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio Table 196. Yeasen Biotechnology (Shanghai) Recent Development Table 197. North America Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 199. North America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2026) Table 200. North America Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032) & (K Units) Table 201. North America Recombinant Human Transforming Growth Factor-β Sales Market Share Forecast by Country (2027-2032) Table 202. North America Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. North America Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026) & (US$ Million) Table 204. North America Recombinant Human Transforming Growth Factor-β Market Share by Country (2021-2026) Table 205. North America Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. North America Recombinant Human Transforming Growth Factor-β Market Share Forecast by Country (2027-2032) Table 207. Europe Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 208. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 209. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2026) Table 210. Europe Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032) & (K Units) Table 211. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share Forecast by Country (2027-2032) Table 212. Europe Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Europe Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026) & (US$ Million) Table 214. Europe Recombinant Human Transforming Growth Factor-β Market Share by Country (2021-2026) Table 215. Europe Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Europe Recombinant Human Transforming Growth Factor-β Market Share Forecast by Country (2027-2032) Table 217. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 218. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 219. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2026) Table 220. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032) & (K Units) Table 221. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share Forecast by Country (2027-2032) Table 222. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026) & (US$ Million) Table 224. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Share by Country (2021-2026) Table 225. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Share Forecast by Country (2027-2032) Table 227. Latin America Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 228. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 229. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2026) Table 230. Latin America Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032) & (K Units) Table 231. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share Forecast by Country (2027-2032) Table 232. Latin America Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Latin America Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026) & (US$ Million) Table 234. Latin America Recombinant Human Transforming Growth Factor-β Market Share by Country (2021-2026) Table 235. Latin America Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Latin America Recombinant Human Transforming Growth Factor-β Market Share Forecast by Country (2027-2032) Table 237. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 238. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 239. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2026) Table 240. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032) & (K Units) Table 241. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share Forecast by Country (2027-2032) Table 242. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 243. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026) & (US$ Million) Table 244. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Share by Country (2021-2026) Table 245. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032) & (US$ Million) Table 246. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Share Forecast by Country (2027-2032) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. Recombinant Human Transforming Growth Factor-β Distributors List Table 250. Recombinant Human Transforming Growth Factor-β Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. Recombinant Human Transforming Growth Factor-β Image Figure 2. Global Recombinant Human Transforming Growth Factor-β Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Transforming Growth Factor-β Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Transforming Growth Factor-β Sales (2021-2032) & (K Units) Figure 5. TGF-β3 Image Figure 6. Global TGF-β3 Sales YoY Growth (2021-2032) & (K Units) Figure 7. TGF-β2 Image Figure 8. Global TGF-β2 Sales YoY Growth (2021-2032) & (K Units) Figure 9. TGF-β1 Image Figure 10. Global TGF-β1 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Recombinant Human Transforming Growth Factor-β Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Recombinant Human Transforming Growth Factor-β Market Share by Type 2025 VS 2032 Figure 13. North America Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Type in 2025 Figure 14. North America Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Type in 2025 Figure 15. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Type in 2025 Figure 16. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Type in 2025 Figure 19. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Research Institute Image Figure 28. Global Research Institute Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Recombinant Human Transforming Growth Factor-β Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Recombinant Human Transforming Growth Factor-β Market Share by Application 2025 VS 2032 Figure 33. North America Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Application in 2025 Figure 34. North America Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Application in 2025 Figure 35. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Application in 2025 Figure 36. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Application in 2025 Figure 39. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share in Value by Application in 2025 Figure 43. North America Recombinant Human Transforming Growth Factor-β Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Recombinant Human Transforming Growth Factor-β Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Recombinant Human Transforming Growth Factor-β Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Human Transforming Growth Factor-β Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Recombinant Human Transforming Growth Factor-β Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Recombinant Human Transforming Growth Factor-β Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Recombinant Human Transforming Growth Factor-β Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Recombinant Human Transforming Growth Factor-β Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Recombinant Human Transforming Growth Factor-β Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Recombinant Human Transforming Growth Factor-β Production Mode & Pr

Scope & coverage.

Types
  • TGF-β3
  • TGF-β2
  • TGF-β1
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • Abcam
  • ACROBiosystems
  • Atlantis Bioscience
  • Bio-Techne
  • Cell Guidance Systems
  • Cell Signaling Technology
  • Croyez Bioscience
  • FUJIFILM Irvine Scientific
  • MedChemExpress
  • Miltenyi Biotec
  • Proteintech
  • Qkine
  • Sigma-Aldrich
  • Beijing T&L Biotechnology
  • Beijing Sino Biological
  • Dalian Meilun Biotechnology
  • Cellverse
  • Nanjing Okay Biotechnology
  • Thermo Fisher
  • Shanghai DiLab Biotechnology
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Suzhou Novoprotein Scientific
  • Abbkine Scientific
  • EIAAB SCIENCE
  • Yeasen Biotechnology (Shanghai)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human Transforming Growth Factor-β Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Human Transforming Growth Factor-β Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Human Transforming Growth Factor-β Market by Type
  6. 1.3.1 TGF-β3
  7. 1.3.2 TGF-β2
  8. 1.3.3 TGF-β1
  9. 1.4 Global Recombinant Human Transforming Growth Factor-β Market Size by Type
  10. 1.4.1 Global Recombinant Human Transforming Growth Factor-β Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Recombinant Human Transforming Growth Factor-β Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Recombinant Human Transforming Growth Factor-β Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Recombinant Human Transforming Growth Factor-β Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Recombinant Human Transforming Growth Factor-β Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Recombinant Human Transforming Growth Factor-β Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Human Transforming Growth Factor-β Industry Trends
  2. 2.2 Recombinant Human Transforming Growth Factor-β Industry Drivers
  3. 2.3 Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Transforming Growth Factor-β Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Human Transforming Growth Factor-β Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Human Transforming Growth Factor-β Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Human Transforming Growth Factor-β Price (2021-2026)
  4. 3.4 Global Recombinant Human Transforming Growth Factor-β Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Transforming Growth Factor-β Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Human Transforming Growth Factor-β Company, Product Type & Application
  7. 3.7 Global Recombinant Human Transforming Growth Factor-β Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Transforming Growth Factor-β Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Transforming Growth Factor-β Tier 1, Tier 2, and Tier 3
4 Recombinant Human Transforming Growth Factor-β Regional Status and Outlook
  1. 4.1 Global Recombinant Human Transforming Growth Factor-β Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Human Transforming Growth Factor-β Historic Market Size by Region
  3. 4.2.1 Global Recombinant Human Transforming Growth Factor-β Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Human Transforming Growth Factor-β Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Human Transforming Growth Factor-β Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Human Transforming Growth Factor-β Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Human Transforming Growth Factor-β Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Human Transforming Growth Factor-β Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Human Transforming Growth Factor-β Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Human Transforming Growth Factor-β by Application
  1. 5.1 Recombinant Human Transforming Growth Factor-β Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Recombinant Human Transforming Growth Factor-β Market Size by Application
  6. 5.2.1 Global Recombinant Human Transforming Growth Factor-β Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Recombinant Human Transforming Growth Factor-β Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Recombinant Human Transforming Growth Factor-β Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Recombinant Human Transforming Growth Factor-β Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Recombinant Human Transforming Growth Factor-β Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Recombinant Human Transforming Growth Factor-β Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abcam
  2. 6.1.1 Abcam Company Information
  3. 6.1.2 Abcam Business Overview
  4. 6.1.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
  6. 6.1.5 Abcam Recent Developments
  7. 6.2 ACROBiosystems
  8. 6.2.1 ACROBiosystems Company Information
  9. 6.2.2 ACROBiosystems Business Overview
  10. 6.2.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
  12. 6.2.5 ACROBiosystems Recent Developments
  13. 6.3 Atlantis Bioscience
  14. 6.3.1 Atlantis Bioscience Company Information
  15. 6.3.2 Atlantis Bioscience Business Overview
  16. 6.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  18. 6.3.5 Atlantis Bioscience Recent Developments
  19. 6.4 Bio-Techne
  20. 6.4.1 Bio-Techne Company Information
  21. 6.4.2 Bio-Techne Business Overview
  22. 6.4.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
  24. 6.4.5 Bio-Techne Recent Developments
  25. 6.5 Cell Guidance Systems
  26. 6.5.1 Cell Guidance Systems Company Information
  27. 6.5.2 Cell Guidance Systems Business Overview
  28. 6.5.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
  30. 6.5.5 Cell Guidance Systems Recent Developments
  31. 6.6 Cell Signaling Technology
  32. 6.6.1 Cell Signaling Technology Company Information
  33. 6.6.2 Cell Signaling Technology Business Overview
  34. 6.6.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
  36. 6.6.5 Cell Signaling Technology Recent Developments
  37. 6.7 Croyez Bioscience
  38. 6.7.1 Croyez Bioscience Company Information
  39. 6.7.2 Croyez Bioscience Business Overview
  40. 6.7.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  42. 6.7.5 Croyez Bioscience Recent Developments
  43. 6.8 FUJIFILM Irvine Scientific
  44. 6.8.1 FUJIFILM Irvine Scientific Company Information
  45. 6.8.2 FUJIFILM Irvine Scientific Business Overview
  46. 6.8.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  48. 6.8.5 FUJIFILM Irvine Scientific Recent Developments
  49. 6.9 MedChemExpress
  50. 6.9.1 MedChemExpress Company Information
  51. 6.9.2 MedChemExpress Business Overview
  52. 6.9.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
  54. 6.9.5 MedChemExpress Recent Developments
  55. 6.10 Miltenyi Biotec
  56. 6.10.1 Miltenyi Biotec Company Information
  57. 6.10.2 Miltenyi Biotec Business Overview
  58. 6.10.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
  60. 6.10.5 Miltenyi Biotec Recent Developments
  61. 6.11 Proteintech
  62. 6.11.1 Proteintech Company Information
  63. 6.11.2 Proteintech Business Overview
  64. 6.11.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
  66. 6.11.5 Proteintech Recent Developments
  67. 6.12 Qkine
  68. 6.12.1 Qkine Company Information
  69. 6.12.2 Qkine Business Overview
  70. 6.12.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
  72. 6.12.5 Qkine Recent Developments
  73. 6.13 Sigma-Aldrich
  74. 6.13.1 Sigma-Aldrich Company Information
  75. 6.13.2 Sigma-Aldrich Business Overview
  76. 6.13.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
  78. 6.13.5 Sigma-Aldrich Recent Developments
  79. 6.14 Beijing T&L Biotechnology
  80. 6.14.1 Beijing T&L Biotechnology Company Information
  81. 6.14.2 Beijing T&L Biotechnology Business Overview
  82. 6.14.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  84. 6.14.5 Beijing T&L Biotechnology Recent Developments
  85. 6.15 Beijing Sino Biological
  86. 6.15.1 Beijing Sino Biological Company Information
  87. 6.15.2 Beijing Sino Biological Business Overview
  88. 6.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
  90. 6.15.5 Beijing Sino Biological Recent Developments
  91. 6.16 Dalian Meilun Biotechnology
  92. 6.16.1 Dalian Meilun Biotechnology Company Information
  93. 6.16.2 Dalian Meilun Biotechnology Business Overview
  94. 6.16.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  96. 6.16.5 Dalian Meilun Biotechnology Recent Developments
  97. 6.17 Cellverse
  98. 6.17.1 Cellverse Company Information
  99. 6.17.2 Cellverse Business Overview
  100. 6.17.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
  102. 6.17.5 Cellverse Recent Developments
  103. 6.18 Nanjing Okay Biotechnology
  104. 6.18.1 Nanjing Okay Biotechnology Company Information
  105. 6.18.2 Nanjing Okay Biotechnology Business Overview
  106. 6.18.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  108. 6.18.5 Nanjing Okay Biotechnology Recent Developments
  109. 6.19 Thermo Fisher
  110. 6.19.1 Thermo Fisher Company Information
  111. 6.19.2 Thermo Fisher Business Overview
  112. 6.19.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
  114. 6.19.5 Thermo Fisher Recent Developments
  115. 6.20 Shanghai DiLab Biotechnology
  116. 6.20.1 Shanghai DiLab Biotechnology Company Information
  117. 6.20.2 Shanghai DiLab Biotechnology Business Overview
  118. 6.20.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  120. 6.20.5 Shanghai DiLab Biotechnology Recent Developments
  121. 6.21 Shanghai Zhong Qiao Xin Zhou Biotechnology
  122. 6.21.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  123. 6.21.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  124. 6.21.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  126. 6.21.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  127. 6.22 Suzhou Novoprotein Scientific
  128. 6.22.1 Suzhou Novoprotein Scientific Company Information
  129. 6.22.2 Suzhou Novoprotein Scientific Business Overview
  130. 6.22.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  132. 6.22.5 Suzhou Novoprotein Scientific Recent Developments
  133. 6.23 Abbkine Scientific
  134. 6.23.1 Abbkine Scientific Company Information
  135. 6.23.2 Abbkine Scientific Business Overview
  136. 6.23.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  138. 6.23.5 Abbkine Scientific Recent Developments
  139. 6.24 EIAAB SCIENCE
  140. 6.24.1 EIAAB SCIENCE Company Information
  141. 6.24.2 EIAAB SCIENCE Business Overview
  142. 6.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
  144. 6.24.5 EIAAB SCIENCE Recent Developments
  145. 6.25 Yeasen Biotechnology (Shanghai)
  146. 6.25.1 Yeasen Biotechnology (Shanghai) Company Information
  147. 6.25.2 Yeasen Biotechnology (Shanghai) Business Overview
  148. 6.25.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
  150. 6.25.5 Yeasen Biotechnology (Shanghai) Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Human Transforming Growth Factor-β Sales by Country
  2. 7.1.1 North America Recombinant Human Transforming Growth Factor-β Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Human Transforming Growth Factor-β Market Size by Country
  6. 7.2.1 North America Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Human Transforming Growth Factor-β Sales by Country
  2. 8.1.1 Europe Recombinant Human Transforming Growth Factor-β Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Human Transforming Growth Factor-β Market Size by Country
  6. 8.2.1 Europe Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Human Transforming Growth Factor-β Sales by Country
  2. 10.1.1 South America Recombinant Human Transforming Growth Factor-β Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Human Transforming Growth Factor-β Market Size by Country
  6. 10.2.1 South America Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Human Transforming Growth Factor-β Value Chain Analysis
  2. 12.1.1 Recombinant Human Transforming Growth Factor-β Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Human Transforming Growth Factor-β Production Mode & Process
  7. 12.2 Recombinant Human Transforming Growth Factor-β Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Human Transforming Growth Factor-β Distributors
  10. 12.2.3 Recombinant Human Transforming Growth Factor-β Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst